Baker Brothers Advisors - CHELSEA THERAPEUTICS INTL LT ownership

CHELSEA THERAPEUTICS INTL LT's ticker is CHTP and the CUSIP is 163428105. A total of 60 filers reported holding CHELSEA THERAPEUTICS INTL LT in Q2 2013. The put-call ratio across all filers is 2.26 and the average weighting 0.1%.

Quarter-by-quarter ownership
Baker Brothers Advisors ownership history of CHELSEA THERAPEUTICS INTL LT
ValueSharesWeighting
Q1 2014$37,317,000
+45.2%
6,760,394
+16.7%
0.47%
+30.9%
Q4 2013$25,700,000
+48.3%
5,794,7530.0%0.36%
+47.2%
Q3 2013$17,326,000
+57.7%
5,794,753
+21.3%
0.25%
+13.4%
Q2 2013$10,984,0004,775,7870.22%
Other shareholders
CHELSEA THERAPEUTICS INTL LT shareholders Q2 2013
NameSharesValueWeighting ↓
VHCP Management, LLC 2,516,870$5,789,0004.30%
Perceptive Advisors 4,658,680$10,714,0001.08%
Baker Brothers Advisors 4,775,787$10,984,0000.22%
FIRST MIDWEST BANK TRUST DIVISION 142,671$328,0000.07%
TFS CAPITAL LLC 470,423$1,082,0000.04%
Geduld E E 25,000$58,0000.04%
DEERE & CO 241,081$554,0000.03%
HIGHLAND CAPITAL MANAGEMENT LP 80,000$184,0000.01%
PRELUDE CAPITAL MANAGEMENT, LLC 21,000$48,0000.01%
GROUP ONE TRADING, L.P. 106,199$244,0000.01%
View complete list of CHELSEA THERAPEUTICS INTL LT shareholders